304 filings
Page 4 of 16
424B5
APRE
Aprea Therapeutics Inc
22 Feb 23
Prospectus supplement for primary offering
4:25pm
8-K
APRE
Aprea Therapeutics Inc
13 Feb 23
Other Events
5:34pm
8-K
APRE
Aprea Therapeutics Inc
13 Feb 23
Aprea Therapeutics Announces One-for-Twenty Reverse Stock Split
7:08am
8-K
APRE
Aprea Therapeutics Inc
10 Feb 23
Other Events
4:31pm
4
Hamill John P.
30 Jan 23
Aprea Therapeutics / John P. Hamill ownership change
5:21pm
3
APRE
Aprea Therapeutics Inc
30 Jan 23
Aprea Therapeutics / John P. Hamill ownership change
5:19pm
8-K
APRE
Aprea Therapeutics Inc
30 Jan 23
Aprea Therapeutics Appoints John Hamill as Chief Financial Officer
4:45pm
8-K
APRE
Aprea Therapeutics Inc
26 Jan 23
Other Events
8:00am
8-K
APRE
Aprea Therapeutics Inc
9 Jan 23
Other Events
8:00am
S-8
APRE
Aprea Therapeutics Inc
15 Dec 22
Registration of securities for employees
5:00pm
8-K
APRE
Aprea Therapeutics Inc
17 Nov 22
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
APRE
Aprea Therapeutics Inc
16 Nov 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:29pm
SC 13D/A
APRE
Aprea Therapeutics Inc
15 Nov 22
Aprea Therapeutics / HealthCap VII ownership change
5:08pm
10-Q
2022 Q3
APRE
Aprea Therapeutics Inc
Quarterly report
9 Nov 22
5:01pm
8-K
APRE
Aprea Therapeutics Inc
9 Nov 22
Aprea Therapeutics Reports Third Quarter 2022 Financial Results and Provides Update on Business Operations
4:23pm
DEF 14A
APRE
Aprea Therapeutics Inc
Definitive proxy
26 Oct 22
5:00pm
PRE 14A
APRE
Aprea Therapeutics Inc
Preliminary proxy
11 Oct 22
5:00pm
8-K
APRE
Aprea Therapeutics Inc
16 Sep 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
424B5
APRE
Aprea Therapeutics Inc
2 Sep 22
Prospectus supplement for primary offering
4:46pm
8-K
APRE
Aprea Therapeutics Inc
19 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm